NNLX.US Nanologix Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Feb 7, 2026
0.0001 0.0001
Market cap
USD 15.9K
P/E
-
P/B
-
ROE
-211.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2013.

Is NNLX.US undervalued?

Graham number

The Graham number of Nanologix Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nanologix Inc fundamental analysis

No fundamental analysis for Nanologix Inc yet.

Nanologix Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nanologix Inc

NanoLogix, Inc., a biotechnology company, provides diagnostics of viable microorganisms and viruses. It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorganisms for pharmaceutical, industrial, veterinary, and environmental testing, as well as microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharm…

Full company profile